The growing interest in potent weight management has led to considerable research into novel treatments. Lately , Retatrutide, a twin-action hormone and glucagon-like peptide-1 (GLP-1) receptor agonist , has exhibited encouraging results in clinical trials, suggesting potential for significant weight loss . Therefore, several individuals are lookin